HomeCompareHRPMF vs EPRT

HRPMF vs EPRT: Dividend Comparison 2026

HRPMF yields 56.98% · EPRT yields 3.92%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 HRPMF wins by $497.8K in total portfolio value
10 years
HRPMF
HRPMF
● Live price
56.98%
Share price
$3.51
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$561.2K
Annual income
$126,052.94
Full HRPMF calculator →
EPRT
EPRT
● Live price
3.92%
Share price
$30.77
Annual div
$1.21
5Y div CAGR
29%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$63.4K
Annual income
$12,840.73
Full EPRT calculator →

Portfolio growth — HRPMF vs EPRT

📍 HRPMF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodHRPMFEPRT
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, HRPMF + EPRT cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
HRPMF pays
EPRT pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HRPMF
Annual income on $10K today (after 15% tax)
$4,843.30/yr
After 10yr DRIP, annual income (after tax)
$107,145.00/yr
EPRT
Annual income on $10K today (after 15% tax)
$332.87/yr
After 10yr DRIP, annual income (after tax)
$10,914.62/yr
At 15% tax rate, HRPMF beats the other by $96,230.38/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HRPMF + EPRT for your $10,000?

HRPMF: 50%EPRT: 50%
100% EPRT50/50100% HRPMF
Portfolio after 10yr
$312.3K
Annual income
$69,446.83/yr
Blended yield
22.24%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EPRT right now

HRPMF
No analyst data
Altman Z
-40.5
Piotroski
2/9
EPRT
Analyst Ratings
1
Strong
17
Buy
3
Hold
1
Sell
Consensus: Buy
Price Target
$35.50
+15.4% upside vs current
Range: $33.00 — $37.00
Altman Z
1.8
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HRPMF buys
0
EPRT buys
0
No recent congressional trades found for HRPMF or EPRT in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricHRPMFEPRT
Forward yield56.98%3.92%
Annual dividend / share$2.00$1.21
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%29%
Portfolio after 10y$561.2K$63.4K
Annual income after 10y$126,052.94$12,840.73
Total dividends collected$460.7K$37.9K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: HRPMF vs EPRT ($10,000, DRIP)

YearHRPMF PortfolioHRPMF Income/yrEPRT PortfolioEPRT Income/yrGap
1← crossover$16,398$5,698.01$11,205$505.18+$5.2KHRPMF
2$26,278$8,732.33$12,672$682.46+$13.6KHRPMF
3$41,196$13,078.29$14,490$930.48+$26.7KHRPMF
4$63,241$19,161.35$16,786$1,282.69+$46.5KHRPMF
5$95,159$27,490.76$19,753$1,791.56+$75.4KHRPMF
6$140,479$38,659.15$23,677$2,541.64+$116.8KHRPMF
7$203,650$53,337.34$29,008$3,672.99+$174.6KHRPMF
8$290,169$72,263.73$36,463$5,425.08+$253.7KHRPMF
9$406,709$96,228.48$47,238$8,221.57+$359.5KHRPMF
10$561,232$126,052.94$63,385$12,840.73+$497.8KHRPMF

HRPMF vs EPRT: Complete Analysis 2026

HRPMFStock

Herantis Pharma Oyj, a biotech company, engages in the development of disease-modifying CDNF-based therapies for Parkinson's disease (PD). Its lead product in pipeline includes HER-096, an advanced small and synthetic chemical peptidomimetic version of the active parent as the preclinical xCDNF candidate for the treatment of PD and other neurodegenerative diseases; and recombinant human Cerebral Dopamine Neurotrophic Factor (rhCDNF), a biological protein that is in Phase I study in patients with PD. The company was incorporated in 2008 and is based in Espoo, Finland.

Full HRPMF Calculator →

EPRTREIT

Essential Properties Realty Trust, Inc., a real estate company, acquires, owns, and manages single-tenant properties in the United States. The company leases its properties to middle-market companies, such as restaurants, car washes, automotive services, medical and dental services, convenience stores, equipment rental, entertainment, early childhood education, grocery, and health and fitness on a long-term basis. As of December 31, 2021, it had a portfolio of 1, 451 properties. The company qualifies as a real estate investment trust for federal income tax purposes. It generally would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders. The company was founded in 2016 and is headquartered in Princeton, New Jersey.

Full EPRT Calculator →
📬

Get this HRPMF vs EPRT comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HRPMF vs SCHDHRPMF vs JEPIHRPMF vs OHRPMF vs KOHRPMF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.